Recent studies have demonstrated that BRD4 binds preferentially to super enhancers (SEs), long stretches of enhancers that control the expression of ‘cell identity’ genes in normal cells and tumor‐specific oncogenes in cancer cells 22. This evidence concerns the gene BRD4 and neoplasm.